TN HB 2246
enactedHealth Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.
Tennessee · 114S1 · lower
- Introduced
- 2026-02-04
- Status date
- —
- Latest action
- 2026-05-26 — Pub. Ch. 1016
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Hurtprimary
Committees
Not provided by source.
Action timeline
2026-02-02
Filed for introduction
filing
2026-02-04
Intro., P1C.
introduction
2026-02-05
Assigned to s/c Health Subcommittee
referral-committee
2026-02-05
P2C, ref. to Health Committee - Government Operations for Review
referral-committee
2026-03-04
Placed on s/c cal Health Subcommittee for 3/11/2026
2026-03-11
Placed on s/c cal Health Subcommittee for 3/18/2026
2026-03-11
Action Def. in s/c Health Subcommittee to 3/18/2026
2026-03-18
Placed on cal. Health Committee for 3/24/2026
2026-03-18
Rec for pass if am by s/c ref. to Health Committee
referral-committee
2026-03-20
Sponsor(s) Added.
sponsorship
2026-03-24
Action def. in Health Committee to 3/31/2026
2026-03-25
Placed on cal. Health Committee for 3/31/2026
2026-03-31
Rec. for pass. if am., ref. to Government Operations Committee
committee-passage-favorable
2026-04-01
Placed on cal. Government Operations Committee for 4/6/2026
2026-04-06
Rec. for pass; ref to Calendar & Rules Committee
committee-passage-favorable
2026-04-08
Placed on cal. Calendar & Rules Committee for 4/9/2026
2026-04-09
H. Placed on Regular Calendar for 4/13/2026
2026-04-13
Engrossed; ready for transmission to Sen.
receipt
2026-04-13
Passed H., as am., Ayes 92, Nays 0, PNV 2
passage
2026-04-13
H. adopted am. (Amendment 1 - HA0940)
amendment-passage
2026-04-14
Received from House, Passed on First Consideration
introduction
2026-04-16
Passed Senate, Ayes 31, Nays 0
passage
2026-04-16
Amendment withdrawn. (Amendment 1 - SA0975)
2026-04-16
Senate substituted House Bill for companion Senate Bill.
substitution
2026-04-29
Enrolled; ready for sig. of H. Speaker.
enrolled
2026-04-30
Signed by H. Speaker
passage
2026-05-05
Signed by Senate Speaker
passage
2026-05-07
Transmitted to Governor for his action.
executive-receipt
2026-05-19
Signed by Governor.
executive-signature
2026-05-26
Effective date(s) 05/19/2026, 07/01/2026
2026-05-26
Pub. Ch. 1016
Versions
Documents
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- (no extracted text yet)
- (no extracted text yet)
Votes
HOUSE HEALTH SUBCOMMITTEE: Rec for pass if am by s/c ref. to Health Committee 3/18/2026 Passed (5)
2026-03-18 · pass · 7-0
HOUSE HEALTH COMMITTEE: Rec. for pass. if am., ref. to Government Operations Committee 3/31/2026 Passed (4)
2026-03-31 · pass · 19-0
HOUSE GOVERNMENT OPERATIONS COMMITTEE: Rec. for pass; ref to Calendar & Rules Committee 4/6/2026 Passed (3)
2026-04-06 · pass · 10-0
HOUSE CALENDAR & RULES COMMITTEE: H. Placed on Regular Calendar for 4/13/2026 4/9/2026 (2)
2026-04-13 · fail · 0-0
FLOOR VOTE: REGULAR CALENDAR AS AMENDED PASSAGE ON THIRD CONSIDERATION 4/13/2026 Passed (1)
2026-04-13 · pass · 92-0
Member-level votes (2)
- Pearson: not voting
- Salinas: not voting
FLOOR VOTE: Third Consideration 4/16/2026 Passed (1)
2026-04-16 · pass · 31-0
Related bills
- Companion bill: SB 2586
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:32:51.339172Z
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TN&identifier=HB 2246. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.